August 8, 2007 Peplin Limited [SUBSCRIBER] Subscription AgreementPeplin Inc • September 28th, 2007 • Pharmaceutical preparations
Company FiledSeptember 28th, 2007 IndustryA The Company is seeking to raise an aggregate amount of approximately A$20 million by way of a placement to institutional investors.
TERMINATION AND SETTLEMENT AGREEMENTTermination and Settlement Agreement • September 28th, 2007 • Peplin Inc • Pharmaceutical preparations • California
Contract Type FiledSeptember 28th, 2007 Company Industry JurisdictionThis Termination and Settlement Agreement is entered into this 7th day of October, 2004 (“Effective Date”) between Allergan Sales, LLC (“Allergan”) and Peplin Operations Pty Ltd. (“Peplin”) and their guarantors, Allergan, Inc., and Peplin Ltd. (formerly, Peplin Biotech Ltd.) (hereinafter referred to as “Agreement”).
Contents page iPeplin Inc • September 28th, 2007 • Pharmaceutical preparations • New South Wales
Company FiledSeptember 28th, 2007 Industry JurisdictionPeplin, Inc a company incorporated in Delaware, United States of America of 6475 Christie Avenue, Emeryville, CA 94608, United States of America (Peplin)
CLINICAL SERVICES MASTER AGREEMENTClinical Services Master Agreement • September 28th, 2007 • Peplin Inc • Pharmaceutical preparations • Queensland
Contract Type FiledSeptember 28th, 2007 Company Industry JurisdictionTHIS CLINICAL SERVICES MASTER AGREEMENT (this “Master Agreement”) is entered into as of this 1st day of June, 2005, by and between Peplin Operations Pty Ltd ACN 093 317 367 (“Sponsor”) of Level 2, 1 Breakfast Creek Road, Newstead in the state of Queensland, Australia and Omnicare CR, Inc., (“Omnicare CR”) a Delaware corporation.